- Home
- BMRN vs GNRC Comparison
BMRN vs GNRC Comparison
Compare BMRN & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- GNRC
- Stock Information
- Founded
- BMRN 1996
- GNRC 1959
- Country
- BMRN United States
- GNRC United States
- Employees
- BMRN N/A
- GNRC N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- GNRC Metal Fabrications
- Sector
- BMRN Health Care
- GNRC Consumer Discretionary
- Exchange
- BMRN Nasdaq
- GNRC Nasdaq
- Market Cap
- BMRN 10.5B
- GNRC 8.9B
- IPO Year
- BMRN 1999
- GNRC 2010
- Fundamental
- Price
- BMRN $54.46
- GNRC $139.72
- Analyst Decision
- BMRN Buy
- GNRC Buy
- Analyst Count
- BMRN 19
- GNRC 18
- Target Price
- BMRN $90.26
- GNRC $188.72
- AVG Volume (30 Days)
- BMRN 2.8M
- GNRC 1.5M
- Earning Date
- BMRN 10-27-2025
- GNRC 10-29-2025
- Dividend Yield
- BMRN N/A
- GNRC N/A
- EPS Growth
- BMRN 59.53
- GNRC 9.08
- EPS
- BMRN 2.68
- GNRC 5.26
- Revenue
- BMRN $3,094,001,000.00
- GNRC $4,352,444,000.00
- Revenue This Year
- BMRN $13.32
- GNRC $2.33
- Revenue Next Year
- BMRN $7.51
- GNRC $10.85
- P/E Ratio
- BMRN $20.33
- GNRC $26.73
- Revenue Growth
- BMRN 12.39
- GNRC 5.52
- 52 Week Low
- BMRN $50.76
- GNRC $99.50
- 52 Week High
- BMRN $73.51
- GNRC $203.25
- Technical
- Relative Strength Index (RSI)
- BMRN 53.97
- GNRC 28.57
- Support Level
- BMRN $53.67
- GNRC $149.86
- Resistance Level
- BMRN $55.34
- GNRC $163.93
- Average True Range (ATR)
- BMRN 1.59
- GNRC 9.08
- MACD
- BMRN 0.31
- GNRC -2.38
- Stochastic Oscillator
- BMRN 81.22
- GNRC 1.79
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.